In many ways, U.S. health care is the envy of the world—it has helped many individuals live longer than ever and enjoy a better quality of life than previously possible. However, we continue to face the challenge of making quality health care more affordable, more accessible, and more reliable for all Americans.
The Chamber is focused on promoting effective private sector solutions to our health care challenges that will help control costs, expand access, and improve the quality of care.
The Chamber's health care priorities include:
Opioid abuse and addiction to illegal opioids has become a nation-wide epidemic with a tremendous peril on human lives, the labor participation rate, businesses, and economic growth.
This letter was sent to the U.S. House of Representatives supporting H.R. 2207, a bill to repeal the tax on medical devices.
This letter was sent to the United States Senate, opposing S. 61, the “Safe and Affordable Drugs from Canada Act of 2019.”
WASHINGTON, D.C. — The U.S. Chamber of Commerce today expressed disappointment about the recent decision from the U.S. District Court for the District of Columbia which found two core provisions of the Department of Labor’s (DOL) Association Health Plan (AHP) Final Rule unlawful.
The U.S. Chamber will continue to work to support this policy in the courts.
In 2017 alone, we lost more than 47,000 Americans to opioid overdose.
This letter was sent to the United States Senate supporting S. 692, a bill to repeal the tax on medical devices.
This letter was sent to the U.S. House of Representatives opposing H.R. 1384, the Medicare for All proposal, and H.R. 1346, the Medicare Buy-In proposal.
This letter was sent to the U.S. Senate opposing Medicare for All and Medicare Buy-In proposals.
MIAMI, Fla.—Today, the U.S.
From shipping to staffing, the Chamber and its partners have the tools to save your business money and the solutions to help you run it more efficiently. Join the U.S. Chamber of Commerce today to start saving.
Weekly insights and analysis from the intersection of government and business.
Comments to HHS Supporting Removal of Safe Harbor Protection for Rebates
This letter was submitted to the Department of Health and Human Services, supporting the removal of safe harbor protection for rebates involving prescription pharmaceuticals and creation of new safe harbor protections for certain point-of-sale reductions in price on prescription pharmaceuticals and certain pharmacy benefit manager service fees.